Pharmaceutical formulation comprising fulvestrant

摘要

A sustained release pharmaceutical formulation for intra-muscular administration comprising fulvestrant in a ricinoleate vehicle, a pharmaceutically acceptable non-aqueous ester solvent and a pharmaceutically acceptable alcohol. The formulation provides for the blood plasma fulvestrant concentration of at least 2.5 ng/ml for at least two weeks.